These results imply that Nic treatment led to downregulation of CyclinD1, which in turn caused the arrest of breast cancer cells (MDA-MB-231 and MCF7) in the G0/G1 phase of their cell cycle. The gene discussed is CCND1; the disease is breast cancer.